Algernon Pharmaceuticalsinc (AGN.CN)
0.0800 x 22000 0.0900 x 14000
Post-market by (Cboe BZX)
0.0850 -0.0050 (-5.56%) 03/17/25 [CNSX]
0.0800 x 22000 0.0900 x 14000
Post-market 0.0850 unch (unch) 15:59 ET
for Mon, Mar 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2024 | 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 27 | 50 | 35 | N/A | 0 |
| Accounts receivable | 80 | 568 | 1,614 | -1,151 | -1,123 |
| Other Working Capital | -616 | 1,266 | 2,584 | -598 | -1,069 |
| Other Operating Activity | -2,200 | -4,437 | -7,147 | -6,074 | -4,418 |
| Operating Cash Flow | $-2,710 | $-2,553 | $-2,913 | $-7,823 | $-6,610 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | 2,630 | -60 | -145 | -124 | -100 |
| Other Investing Activity | 2,364 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $2,280 | $-60 | $-145 | $-124 | $-100 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 894 | 1,226 | 2,055 | 2,694 | 9,259 |
| Other Financing Activity | 8 | 103 | 0 | 1,552 | 3,361 |
| Financing Cash Flow | $901 | $1,329 | $2,055 | $4,245 | $12,620 |
| Exchange Rate Effect | 0 | 0 | 0 | -8 | 4 |
| Beginning Cash Position | 125 | 1,409 | 2,411 | 6,121 | 208 |
| End Cash Position | 596 | 125 | 1,409 | 2,411 | 6,121 |
| Net Cash Flow | $471 | $-1,284 | $-1,002 | $-3,702 | $5,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,710 | -2,553 | -2,913 | -7,823 | -6,610 |
| Capital Expenditure | -84 | -60 | -145 | -124 | -100 |
| Free Cash Flow | -2,794 | -2,613 | -3,057 | -7,947 | -6,710 |